Dean Rudge's profile photo

Dean Rudge

Birmingham

Deputy Editor at Generics Bulletin

Assistant editor at Generics bulletin

Featured in: Favicon informa.com (+4) Favicon manchestereveningnews.co.uk Favicon walesonline.co.uk Favicon birminghammail.co.uk Favicon liverpoolecho.co.uk Favicon chroniclelive.co.uk Favicon coventrytelegraph.net Favicon bristolpost.co.uk Favicon hulldailymail.co.uk Favicon football.london

Articles

  • Aurobindo Plots Rivaroxaban Roll-Out As FDA Approves 2.5mg Strength ANDA

    1 week ago | insights.citeline.com | Dean Rudge

    Aurobindo Plots Rivaroxaban Roll-Out As FDA Approves 2.5mg Strength ANDAIndian Firm Settled Litigation In May Last Year; Lupin Recently Launched ‘At Risk’17 Apr 2025Aurobindo is set to join Lupin by competing against Johnson/Bayer’s blockbuster blood thinner Xarelto (rivaroxaban) 2.5mg tablets.

  • Sandoz Admits To Widescale Infringement In Resolving US Rinvoq Patent Tussle

    1 week ago | insights.citeline.com | Dean Rudge

    Sandoz Admits To Widescale Infringement In Resolving US Rinvoq Patent TussleHetero, Aurobindo, Sun Pharma Remain In Litigation Over $6bn JAK InhibitorSandoz has reached an agreement with AbbVie to dismiss without prejudice patent-infringement litigation involving more than 20 patents shielding the originator’s blockbuster JAK inhibitor Rinvoq.

  • Cipla Welcomes Abraxane ANDA Approval After Tackling Goa Compliance Issues

    1 week ago | insights.citeline.com | Dean Rudge

    Cipla Welcomes Abraxane ANDA Approval After Tackling Goa Compliance IssuesOnly Second Abraxane ANDA And Fourth ‘Therapeutic Equivalent’ To BMS BrandCipla will look to give its US operations a boost later this year by launching only the second Abraxane ANDA product.

  • Jazz Agrees To Fork Out $145m To Resolve Most Xyrem ‘Pay-For-Delay’ Claims

    2 weeks ago | insights.citeline.com | Dean Rudge

  • Kabi Pens Agreement To Launch Generic Exparel In 2030 - With A Volume Limit

    2 weeks ago | insights.citeline.com | Dean Rudge

    Kabi Pens Agreement To Launch Generic Exparel In 2030 – With A Volume LimitGerman Firm And Partner Jiangsu Hengrui Face Near Decade Of Cap On VolumesWith sales of $550m last year and a high barrier to entry, Exparel marks an intriguing target for abbreviated new drug application sponsors.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
39
Tweets
73
DMs Open
No
Dean Rudge
Dean Rudge @GbDeanR
2 Dec 24

To quote @NilePowerRanger 'When your is money long, all is possible.' Wow.

TURKI ALALSHIKH
TURKI ALALSHIKH @Turki_alalshikh

One of the greatest cards ever on February 22 in Riyadh 🥊🔥 #BigTime #RiyadhSeason https://t.co/4jQEowMXvD

Dean Rudge
Dean Rudge @GbDeanR
19 Oct 24

Never deleting this app

Twitter User @user

Dean Rudge
Dean Rudge @GbDeanR
30 Aug 24

Happy Friday Blue Noses.

John Percy
John Percy @JPercyTelegraph

Bloody hell, Birmingham City. Bid of around £9-10m has gone in for #Fulham striker Jay Stansfield, who scored 13 goals for Birmingham on loan last season. Blues trying to do a deal before the deadline: will be the most expensive signing ever in League One by a distance #bcfc #kro